LIMN
Liminatus Pharma
$0.10
−$0.01 (−7.21%)Jul 27, 2026
Key metrics
The numbers that frame LIMN today
- Market cap
- $4.62M
- P/E (TTM)
- -0.4
- EV / FCF
- -0.4
- ROIC
- 234.7%
- Div yield
- 0%
- 52wk Low
- $0.10
- 52wk High
- $9.38
Growth
Revenue and earnings trend for LIMN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about LIMN
Is Liminatus Pharma a good buy?
No. Liminatus Pharma has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Liminatus Pharma is selling at a very high price.
What is the market capitalization of LIMN?
Liminatus Pharma's market capitalization is $4.62M.
What is the P/E ratio for LIMN stock?
Liminatus Pharma's current P/E ratio is -0.4.
What is the 52-week high for LIMN stock?
The 52-week high for Liminatus Pharma is $9.38. The current close of $0.10 is 98.9% below that high.
What is the 52-week low for LIMN stock?
The 52-week low for Liminatus Pharma is $0.10. The current close of $0.10 is 8.4% above that low.
Does LIMN stock pay dividends?
Liminatus Pharma does not currently show a dividend per share in the company data.